Brett Jones, University of Toronto

Research

Adolescents Adults Bipolar Affective Disorder Creatine Monohydrate,Feasibility Study Major Depressive Disorder Randomized Controlled Trial Supplementation

Latest papers

A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders.
BMC psychiatry · 2024
Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
JAMA network open · 2019

All 3 publications

Latest funding

Creatine Monohydrate Relative to Placebo for Treatment of Mood Disorders
CIHR · 2026 · Principal investigator
$742,050
Mitochondrial Genetics in Relation to Brain Metabolism and Energy Phenotypes in Bipolar Disorder Across the Lifespan
CIHR · 2026 · Co-investigator
$934,491
Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial
CIHR · 2025 · Co-investigator
$1,510,875

All 5 grants and awards

3 publications.

01

A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders.

Husain MO, Jones B, Arshad U, Ameis SH, Mirfallah G, Schifani C, Rodak T, Aiken M, Shafique M, Ahmed F, Voineskos A, Husain MI, Foussias G

BMC psychiatry2024

DOI: 10.1186/s12888-024-05788-y PMID: 38898401

02

Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data.

Weissman CR, Hadas I, Yu D, Jones B, Kong D, Mulsant BH, Blumberger DM, Daskalakis ZJ

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

DOI: 10.1038/s41386-020-00953-9 PMID: 33479508

03

Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.

Hadas I, Sun Y, Lioumis P, Zomorrodi R, Jones B, Voineskos D, Downar J, Fitzgerald PB, Blumberger DM, Daskalakis ZJ

JAMA network open2019

DOI: 10.1001/jamanetworkopen.2019.5578 PMID: 31167023

Creatine Monohydrate Relative to Placebo for Treatment of Mood Disorders

Principal investigatorCIHR2026Project Grant

Principal investigators: Courtney, Darren; Husain, Muhammad I; Jones, Brett

Keywords: Adolescents; Adults; Bipolar Affective Disorder; Creatine Monohydrate,; Feasibility Study; Major Depressive Disorder; Randomized Controlled Trial; Supplementation

$742,050

Mitochondrial Genetics in Relation to Brain Metabolism and Energy Phenotypes in Bipolar Disorder Across the Lifespan

Co-investigatorCIHR2026Project Grant

Principal investigators: Goldstein, Benjamin I

Keywords: Activity; Bipolar Disorder; Energy; Genetics; Lifespan; Mitochondria; Neuroimaging; Sex Differences

$934,491

Metformin for treatment-resistant bipolar depression (TRBD) with co-morbid insulin resistance (IR): A double-blind randomized control trial

Co-investigatorCIHR2025Project Grant

Principal investigators: Hahn, Margaret; Agarwal, Sri Mahavir; Kloiber, Stefan M; Mansur, Rodrigo B; Saraf, Gayatri; Taylor, Valerie Hannah

Keywords: Bipolar Disorder; Depression; Insulin Resistance; Metformin; Treatment Resistance

$1,510,875

Adjunctive Psilocybin for Treatment Resistant Depression (Ad-Psilo): A Randomized, Active Placebo-Controlled, Phase II Clinical Trial

Co-investigatorCIHR2025Project Grant

Principal investigators: Rosenblat, Joshua D; Husain, Muhammad I; Konstantinou, Gerasimos

Keywords: Clinical Trial; Drug Development; Major Depressive Disorder; Mood Disorders; Pharmacotherapy; Psilocybin; Psychedelics; Psychotherapy; Suicide; Treatment Resistant Depression

$1,503,224

A Pilot Randomized Clinical Trial Comparing Psilocybin with Safety Monitoring Versus Psilocybin-Assisted Therapy for Treatment-Resistant Depression

Co-investigatorCIHR2024Project Grant

Principal investigators: Husain, Muhammad I; Rosenblat, Joshua D

Keywords: Clinical Trial; Psilocybin

$642,600

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Psychiatry
Other

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Christin Schifani

Faculty

1 shared papers, latest 2024

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Adolescents Dear Professor Jones, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders." (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Creatine Monohydrate Relative to Placebo for Treatment of Mood Disorders" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Brett Jones